Abstract Number: 2414 • 2015 ACR/ARHP Annual Meeting
High-Intensity Versus Low-Intensity Physical Activity or Exercises in Patients with Hip or Knee Osteoarthritis: A Meta-Analysis
Background/Purpose: Exercise or physical activity are complex interventions whose effectiveness depends on more than one component. We aimed to determine the benefits and harms of…Abstract Number: 150 • 2015 ACR/ARHP Annual Meeting
A Preliminary Consensus on Core Outcome Domains for Total Joint Replacement Clinical Trials: An Omeract-Based Study
Background/Purpose: Outcomes Measures in Rheumatology Trials (OMERACT) has developed a framework based on the WHO’s International Classification of Functioning, Disability, and Health (ICF) conceptual model. …Abstract Number: 3270 • 2015 ACR/ARHP Annual Meeting
Correction of Limb Length Inequality in Adults with Knee or Hip Symptoms: A Pilot Study
Background/Purpose: Limb length inequality (LLI; paired lower extremities of unequal length) is associated with knee and hip osteoarthritis (OA) and symptoms consistent with OA (pain,…Abstract Number: 181 • 2015 ACR/ARHP Annual Meeting
A Vascular Obstacle in Ultrasound Guided Hip Joint Injection
Background/Purpose: Injury of the lateral circumflex femoral artery (LCFA) is a potential cause of bleeding during invasive hip procedures due to its close proximity to…Abstract Number: 333 • 2015 ACR/ARHP Annual Meeting
Smoking and Knee and Hip Osteoarthritis Evolution. Results from the Knee and Hip Osteoarthritis Long-Terme Assessment Cohort
Background/Purpose: Relations between smoking and osteoarthritis remains discussed. The protective effect found in previous epidemiological studies has not been confirmed by recent studies and meta…Abstract Number: 369 • 2015 ACR/ARHP Annual Meeting
Incidence of Fragility Hip Fractures over 10 Years (2004-13) in Three UK Centres with Reference to Local Fracture Prevention (‘fracture liaison’) Service Activity
Background/Purpose: Fracture Liaison Services systematically identify patients with fragility fracture and screen patients for osteoporosis and associated conditions and instigate evidence-based 'secondary' fracture prevention management.…Abstract Number: 1008 • 2015 ACR/ARHP Annual Meeting
Morphometric Study of Algerian Hips: An Etiological Study to Explain the Low Prevalence of Hip Osteoarthritis in Algeria
Background/Purpose: In western countries, hip osteoarthritis (OA) is the third osteoarthritic location in terms of prevalence, with a ratio hip/knee OA of 1:2 to 1:3. However,…Abstract Number: 1278 • 2015 ACR/ARHP Annual Meeting
An Underlying Diagnosis of Osteoarthritis Is Associated with Better Outcomes after Total Hip Arthroplasty Than Avascular Necrosis of Bone
Background/Purpose: We recently showed that underlying diagnosis of RA was associated with higher readmission rate compared to osteoarthritis. Studies of adequate sample size assessing post-THA…Abstract Number: 1418 • 2015 ACR/ARHP Annual Meeting
The Importance of Comorbidity in Understanding the 6-Month Trajectories of Pain and Function after Total Hip Arthroplasty
Background/Purpose: Osteoarthritis (OA) is chronic condition associated with a number of other comorbidities which may affect the 6 month pattern of recovery of total hip…Abstract Number: 1425 • 2015 ACR/ARHP Annual Meeting
Current Tobacco Use and the Rates of Complications after Total Hip Arthroplasty
Background/Purpose: The risk of postoperative complication with tobacco use disorder and complication after total hip arthroplasty (THA) are not known. Our objective was to compare…Abstract Number: 1497 • 2015 ACR/ARHP Annual Meeting
Panlar Consensus on Hand, Hip and Knee OA
Background/Purpose: The purpose of this Consensus is to update the PANLAR recommendations for hand, hip and knee osteoarthritis (OA) based on a combination of the…Abstract Number: 1834 • 2015 ACR/ARHP Annual Meeting
Total Hip Arthroplasty Outcomes: A 17 Year Experience in a Single-Center: Is Systemic Lupus Erythematosus a Real Risk Factor for Adverse Outcomes?
Background/Purpose: In patients with systemic lupus erythematosus (SLE), persistent joint activity and treatment with glucocorticoids are associated with musculoskeletal complications, including hip osteonecrosis. About 30%…Abstract Number: 1043 • 2014 ACR/ARHP Annual Meeting
Identification of Putative Biomarkers and Molecular Mechanisms Associated with Adverse Tissue Reactions to Metal-on-Metal and Modular Neck Hip Implants
Background/Purpose Total hip replacement (THR) is a highly successful treatment for degenerative arthritis, alleviating pain and restoring joint function in the vast majority of patients.…Abstract Number: 219 • 2014 ACR/ARHP Annual Meeting
DXA Body Composition, Sarcopenia and Knee and Hip Osteoarthritis: Results from the Khoala Cohort
Background/Purpose Obesity is a well known risk factor for the development and progression of knee osteoarthritis (OA), and to a lesser extent of hip OA.…Abstract Number: 199 • 2014 ACR/ARHP Annual Meeting
Increasing Complexity of Patients Undergoing Primary Total Hip Arthroplasty in the U.S
Background/Purpose: To examine the time-trends in key demographic and clinical characteristics of patients undergoing primary total hip arthroplasty (THA).Methods: We used the data from the…